VALBIOTIS (EPA:ALVAL) Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Transparency directive : regulatory news
06/06/2024 10:53
source : webdisclosure.com
VALBIOTIS's latest news
28/11/2024 17:40
28/11/2024 17:40
06/11/2024 17:40
29/10/2024 17:40
15/10/2024 17:40
05/09/2024 17:40
17/06/2024 17:40
06/06/2024 10:53
04/06/2024 08:00
22/05/2024 17:40
Other stories
02/01/2025 20:35
02/01/2025 20:08
02/01/2025 19:28
03/01/2025 01:02
03/01/2025 00:40
03/01/2025 03:06
02/01/2025 20:30
02/01/2025 18:32
02/01/2025 23:30
02/01/2025 10:41
02/01/2025 13:59
02/01/2025 22:14
03/01/2025 01:08
03/01/2025 04:15
02/01/2025 13:57
02/01/2025 15:42
02/01/2025 14:39
02/01/2025 13:04
02/01/2025 08:14
02/01/2025 09:00
02/01/2025 15:36
01/01/2025 22:00
02/01/2025 19:06
02/01/2025 23:00
02/01/2025 21:35
03/01/2025 00:22
03/01/2025 01:19
02/01/2025 20:41
02/01/2025 22:17
02/01/2025 09:29
02/01/2025 17:44
02/01/2025 19:09
01/01/2025 20:35
02/01/2025 14:23
02/01/2025 07:55
02/01/2025 18:19
02/01/2025 20:57
02/01/2025 11:52